Insider Transactions in Q3 2023 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.89%
|
$136,000
$17.21 P/Share
|
|
Sep 15
2023
|
Scott W Morrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+50.0%
|
-
|
|
Aug 23
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.88%
|
$136,000
$17.23 P/Share
|
|
Aug 15
2023
|
Elizabeth Yeu Lin Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
9,506
+37.47%
|
$152,096
$16.8 P/Share
|
|
Jul 19
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,400
-4.98%
|
$48,000
$20.05 P/Share
|
|
Jul 19
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
103,900
-5.14%
|
$1,974,100
$19.66 P/Share
|
|
Jul 12
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.88%
|
$153,000
$17.35 P/Share
|